Risk factors for early mortality among HIV-positive adults on antiretroviral therapy in Ethiopian health facilities

埃塞俄比亚医疗机构中接受抗逆转录病毒治疗的艾滋病毒感染成年人早期死亡的风险因素

阅读:2

Abstract

The rapid expansion of antiretroviral therapy (ART) in Ethiopia has significantly reduced AIDS-related deaths; however, survival rates among people living with HIV (PLHIV) on ART remain variable, and findings on predictors of early mortality are inconsistent. This study aimed to identify factors associated with early mortality among ART users in the Woliso district of Ethiopia. A historical cohort study was conducted among 720 randomly selected ART users from January 2018 to December 2022. Data were collected using Open Data Kit (ODK) and analyzed with STATA 13. Kaplan-Meier survival analysis and Cox proportional hazards regression were employed to assess predictors of mortality. The mortality incidence density was 5.1 per 100 person-years (95% CI: 4.01-6.50). Significant predictors of early mortality included being divorced (AHR: 6.34; 95% CI: 2.05-19.65), advanced WHO clinical stage III/IV (AHR: 2.92; 95% CI: 1.12-8.27), and suboptimal ART adherence-fair (AHR: 5.48; 95% CI: 2.37-12.66) and poor (AHR: 3.50; 95% CI: 1.72-7.09). This study highlights a high early mortality rate, emphasizing the need for early HIV care enrollment and strict treatment adherence to improve survival. Strengthening ART programs with targeted interventions for high-risk groups, such as divorced individuals and those with advanced disease, could further reduce mortality in Ethiopia.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。